The Cost of Complacency

Failing to proactively address drug security isn’t just a minor oversight — it carries serious consequences that affect your practice, your team, and your license.

Legal & Regulatory Consequences:

• DEA Enforcement: Practices can face fines, audits, license suspension, or even criminal charges.
• Civil Penalties: Like in the Dedham case, practices may be fined for each specific violation — improperly stored ketamine could cost thousands per incident.
• State Disciplinary Action: State veterinary boards may take separate action, leading to public censure, license probation, or revocation.

Financial Impact:

• Fines can range from $18,000 to over $1 million, depending on severity and scale.
• Insurance premiums may rise if legal issues arise.
• Staff turnover and retraining can be costly if diversion is traced internally.

Damage to Patient Care & Trust:

• Diversion can lead to improper dosing, missed treatments, or compromised patient care.
• Clients may lose trust in your practice if they suspect drug abuse or hear about regulatory violations.
• Diverted medications might end up in human circulation, contributing to overdose deaths or street drug trafficking.

Operational Breakdown:

• Time lost to DEA investigations or audits.
• Distracted staff, morale issues, and fear of whistleblowing retaliation.
• Loss of efficiency when you must overhaul procedures under scrutiny.

In Summary: Complacency around drug security doesn’t just hurt your bottom line — it can end your practice. Implementing strong diversion prevention measures isn’t optional; it’s essential.